Market Place
Sourcing Support
Ajanta Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.
23 Feb 2024 //
FDA
Medley Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.
14 Feb 2024 //
FDA
USFDA gives final nod to Zydus’ tablets for treatment of seizures
04 Jul 2023 //
FINANCIAL EXPRESS
Zydus` Generic Oxcarbazepine Receives Approval in the U.S.
03 Jul 2023 //
FDA
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Enforcement Report - Week of December 28, 2022
28 Dec 2022 //
FDA
Aucta announced FDA approval of a generic version of Trileptal oral suspension
05 Dec 2022 //
PR NEWSWIRE
Aucta`s Generic Oxcarbazepine Receives Approval in the U.S.
30 Nov 2022 //
FDA
Bionpharma`s Generic Oxcarbazepine Receives Approval in the U.S.
04 Nov 2022 //
FDA
Rubicon`s Generic Oxcarbazepine Receives Approval in the U.S.
30 Aug 2022 //
FDA
Amnora Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.
11 Jan 2022 //
FDA
anti-seizure medication can elevate fracture risk in kids with epilepsy
17 Sep 2021 //
UOFM HEALTH
Glasshouse Pharms`s Generic Oxcarbazepine Receives Approval In US
21 Jun 2021 //
FDA
Glasshouse Pharm’s Generic Oxcarbazepine Receives Approval In US
21 Apr 2021 //
FDA
Enforcement Report - Week of September 25, 2019
26 Sep 2019 //
FDA
Twi Pharms`s Generic Oxcarbazepine Receives Tentative Approval in US
29 Nov 2018 //
FDA
Supernus Pharma to Buy Biscayne Neurotherapeutics in Potential $183 Million Deal
15 Sep 2018 //
BIOSPACE
Real world data back use of Eisai, Bial’s Zebinix in epilepsy
15 Dec 2017 //
PHARMA TIMES
Supernus Wins Appeal Case on Oxtellar XR®
12 Dec 2016 //
GLOBENEWSWIRE
ANI Pharmaceuticals Announces FDA Approval of Oxcarbazepine Tablets
13 Jun 2016 //
PR NEWSWIRE
Japan`s MHLW slated to review Nippon Boehringer high blood pressure combo
13 Apr 2016 //
FIERCE PHARMA ASIA
ViiV Healthcare Announces PhII Study Results for First Two Drug
23 Feb 2016 //
PR NEWSWIRE
Supernus Sues TWi for Infringement of Oxtellar XR(R) Patents
21 Jan 2015 //
SUPERNUS PHARMACEUTICALS
Supernus Sues Par Pharma for Infringement of Trokendi XR Patents
19 Jan 2015 //
SUPERNUS PHARMACEUTICALS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.